Cart
sales@molnova.com
DASA-58
CAS No. 1203494-49-8
DASA-58 ( —— )
Catalog No. M17188 CAS No. 1203494-49-8
DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
Purity : 97%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 311 | In Stock |
|
| 100MG | 492 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDASA-58
-
NoteResearch use only, not for human use.
-
Brief DescriptionDASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
-
DescriptionDASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorPKM2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1203494-49-8
-
Formula Weight453.53
-
Molecular FormulaC19H23N3O6S2
-
Purity97%
-
SolubilityDMSO : ≥ 35 mg/mL 77.17 mM
-
SMILESc1(cc(ccc1)S(=O)(=O)N1CCN(CCC1)S(=O)(=O)c1cc2OCCOc2cc1)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Palsson-McDermott EM, et al. Cell Metab. 2015, 21(1), 65-80.
molnova catalog
related products
-
VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
-
SU-9516
SU9516 is a selectively potent ATP-competitive inhibitor of CDKs.
-
Purvalanol A
A potent, cell-permeable, selective inhibitor of CDK with IC50s of 4, 70, 35, 850, and 75 nM for cdc2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, Cdk4/cyclin D1 and Cdk5-p35, respectively.
